Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Okamoto

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
BMC Cancer|November 29, 2022
Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumorsYuki Yoshikawa, Michio Imamura, Masami Yamauchi, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Communications Medicine|October 25, 2023
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinomaMasami Yamauchi, Atsushi Ono, Kei Amioka, et al.
The Prostate|June 11, 2025
Comprehensive Genomic Profiling Testing for Castration-Resistant Prostate Cancer in Advanced Elderly Patients: A Single-Center Retrospective Cohort StudyTakafumi Fukushima, Keisuke Goto, Yoshinori Nakano, et al.
Cancers|February 27, 2026
Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational StudyNoriaki Iijima, Yasutaka Ishii, Shinya Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal CancerNaoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Journal of Gastroenterology|July 18, 2022
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resectionKenichiro Kodama, Tomokazu Kawaoka, Masanari Kosaka, et al.
Oncology|July 10, 2023
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line LenvatinibKikukawa Chihiro, Tomokazu Kawaoka, Shinsuke Uchikawa, et al.
Cancer Science|October 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancerHiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura, et al.
BMC Gastroenterology|December 22, 2022
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varicesYuki Shirane, Eisuke Murakami, Michio Imamura, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
BMC Cancer|November 29, 2022
Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumorsYuki Yoshikawa, Michio Imamura, Masami Yamauchi, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Communications Medicine|October 25, 2023
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinomaMasami Yamauchi, Atsushi Ono, Kei Amioka, et al.
The Prostate|June 11, 2025
Comprehensive Genomic Profiling Testing for Castration-Resistant Prostate Cancer in Advanced Elderly Patients: A Single-Center Retrospective Cohort StudyTakafumi Fukushima, Keisuke Goto, Yoshinori Nakano, et al.
Cancers|February 27, 2026
Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational StudyNoriaki Iijima, Yasutaka Ishii, Shinya Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal CancerNaoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Journal of Gastroenterology|July 18, 2022
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resectionKenichiro Kodama, Tomokazu Kawaoka, Masanari Kosaka, et al.
Oncology|July 10, 2023
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line LenvatinibKikukawa Chihiro, Tomokazu Kawaoka, Shinsuke Uchikawa, et al.
Cancer Science|October 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancerHiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura, et al.
BMC Gastroenterology|December 22, 2022
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varicesYuki Shirane, Eisuke Murakami, Michio Imamura, et al.
Pageof 10